Effects of probiotics on intermediate cardiovascular outcomes in patients with overweight or obesity: A systematic review and meta-analysis
GLP-1 receptor agonists vs
Summary Keywords Alzheimers disease, clinical trial, cognitive dysfunction, GLP-1 receptor agonist, neuroinflammation, neuroprotection, semaglutide, vascular dementia Citation Alhowail AH, Al Mouslem AK, Almatrafi MA and Aldubayan MA (2026) Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework
CiagliaTVestutoVBertaminoAGonzlez-MuizRGmez-MonterreyI
However, there is ongoing debate about whether MC increases the risk of colon cancer (811)
The modern GLP-1 playbook starts with the right care path, optimizes impact when GLP-1s are taken, and supports long-term maintenance of metabolic health improvements after the medication